Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis.

Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group.

Int J Cancer. 2013 Mar 1;132(5):1146-55. doi: 10.1002/ijc.27717. Epub 2012 Jul 27. Review.

2.

Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer.

Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS.

Am J Epidemiol. 2009 Dec 15;170(12):1512-7. doi: 10.1093/aje/kwp321. Epub 2009 Nov 6.

3.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N; Ovarian Cancer Association Consortium.

J Natl Cancer Inst. 2014 Feb;106(2):djt431. doi: 10.1093/jnci/djt431.

4.

Regular analgesic use and risk of endometrial cancer.

Moysich KB, Baker JA, Rodabaugh KJ, Villella JA.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2923-8.

5.

Use of nonsteroidal anti-inflammatory drugs and risk of endometrial cancer: a nationwide case-control study.

Brøns N, Baandrup L, Dehlendorff C, Kjaer SK.

Cancer Causes Control. 2015 Jul;26(7):973-81. doi: 10.1007/s10552-015-0578-4. Epub 2015 Apr 21.

PMID:
25895439
6.

Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.

Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE.

Cancer Res. 2008 Apr 1;68(7):2507-13. doi: 10.1158/0008-5472.CAN-07-6257.

8.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

9.

Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies.

Zhang H, Jiang D, Li X.

PLoS One. 2013 Jul 19;8(7):e70008. doi: 10.1371/journal.pone.0070008. Print 2013.

10.

Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.

Ammundsen HB, Faber MT, Jensen A, Høgdall E, Blaakaer J, Høgdall C, Kjaer SK.

Acta Obstet Gynecol Scand. 2012 Sep;91(9):1094-102. doi: 10.1111/j.1600-0412.2012.01472.x.

PMID:
22646488
11.

Aspirin and risk of endometrial cancer: a case-control study from Italy.

Bosetti C, Bravi F, Talamini R, Montella M, Negri E, La Vecchia C.

Eur J Cancer Prev. 2010 Sep;19(5):401-3.

PMID:
20698055
12.

Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis.

Nagle CM, Olsen CM, Ibiebele TI, Spurdle AB, Webb PM; Astralian National Endometrial Cancer Study Group; Astralian Ovarian Cancer Study Group.

Eur J Nutr. 2013 Mar;52(2):705-15. doi: 10.1007/s00394-012-0376-7. Epub 2012 May 22. Review.

PMID:
22648201
13.

The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus.

Thrift AP, Pandeya N, Smith KJ, Green AC, Webb PM, Whiteman DC.

Aliment Pharmacol Ther. 2011 Nov;34(10):1235-44. doi: 10.1111/j.1365-2036.2011.04855.x. Epub 2011 Oct 3.

14.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

15.

Analgesic drug use and risk of epithelial ovarian cancer.

Hannibal CG, Rossing MA, Wicklund KG, Cushing-Haugen KL.

Am J Epidemiol. 2008 Jun 15;167(12):1430-7. doi: 10.1093/aje/kwn082. Epub 2008 Apr 4.

16.

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

Murad AS, Down L, Davey Smith G, Donovan JL, Athene Lane J, Hamdy FC, Neal DE, Martin RM.

Int J Cancer. 2011 Mar 15;128(6):1442-8. doi: 10.1002/ijc.25465.

17.

Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals.

Martínez ME, McPherson RS, Levin B, Annegers JF.

Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):703-7.

18.

Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.

Genkinger JM, De Vivo I, Stampfer MJ, Giovannucci E, Michaud DS.

Int J Cancer. 2007 May 15;120(10):2221-5.

19.

Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies.

Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK.

Gynecol Oncol. 2016 Feb;140(2):352-8. doi: 10.1016/j.ygyno.2015.12.009. Epub 2015 Dec 14. Review.

PMID:
26701413
20.

Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women.

Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Cai H, Fair AM, Shu XO, Zheng W.

Breast Cancer Res Treat. 2014 Jul;146(2):439-46. doi: 10.1007/s10549-014-3030-7. Epub 2014 Jul 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk